Alteration on the expression of IL-1, PDGF, TGF-β, EGF, and FGF receptors and c-Fos and c-Myc proteins in bone marrow mesenchymal stroma cells from advanced untreated lung and breast cancer patients

Stem Cells and Development

Volumn 14, Issue 5, 2005, Pages 587-594

  Hofer, Erica Leonor ^a   La Russa, Vincent ^b   Honegger, Alba Elizabeth ^a   Bullorsky, Eduardo Oscar ^c   Bordenave, Raúl Horacio ^d   Chasseing, Norma Alejandra ^a  

^a INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HOSPITAL BRITÁNICO DE BUENOS AIRES   (Argentina)

^d HOSPITAL DURAND   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 20; CYTOKERATIN 7; EPIDERMAL GROWTH FACTOR RECEPTOR; EPITHELIAL MEMBRANE ANTIGEN; FIBROBLAST GROWTH FACTOR RECEPTOR; INTERLEUKIN 1 RECEPTOR; MONOCLONAL ANTIBODY; MYC PROTEIN; ONCOPROTEIN; PLATELET DERIVED GROWTH FACTOR RECEPTOR; POLYCLONAL ANTIBODY; PROTEIN C FOS; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; BONE MARROW CELL; BONE MARROW METASTASIS; BREAST CARCINOMA; CANCER INFILTRATION; CELL PROLIFERATION; COLONY FORMING UNIT F; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STROMA CELL;

ANIMALS; BONE MARROW CELLS; BREAST NEOPLASMS; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; FEMALE; FIBROBLASTS; HUMANS; LUNG NEOPLASMS; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, FIBROBLAST GROWTH FACTOR; RECEPTORS, INTERLEUKIN-1; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; STROMAL CELLS; TUMOR STEM CELL ASSAY;

EID: 28844488762     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2005.14.587     Document Type: Article

References (32)

1. Hung SC, NJ Chen, SL Hsieh, H Li, HL Ma, and WH Lo. (2002). Isolation and Characterization of size-sieved stem cells from human bone marrow. Stem Cells 20:249-258.
2. La Russa V, P Schwarzenberger, A Miller, K Agrawal, J Kolls, and R Weiner. (2002). Marrow stem cells, mesenchymal progenitor and stromal progeny. Cancer Investigation 20:110-132.
3. Beresford JN. (1989). Osteogenic stem cells and the stromal system of bone and marrow. Clin Orthop 240:270-280.
4. Tocci A and L Forte. (2003). Mesenchymal stem cell: use and perspectives. Hematology 4(2):92-96.
5. Alhadlaq A and JJ Mao. (2004). Mesenchymal stem cells: isolation and therapeutics. Stem Cells Dev 13:436-448.
6. Mauney JR, DL Kaplan, and V Volloch. (2004). Matrix-mediated retention of osteogenic differentiation potential by human adult bone marrow stromal cells during ex vivo expansion. Biomaterials 25:3233-3243.
7. Rougier F, F Dupuis, and Y Denizot. (1996). Human bone marrow fibroblasts an overview of their characterization, proliferation and inflammatory mediator production. Hematol Cell Ther 38:241-246.
8. Krebsbach PH, SA Kuznetsov, P Bianco, and PG Robey. (1999). Bone marrow stromal cells: characterization and clinical application. Crit Rev Oral Biol Med 10:165-181.
9. Friedenstein AJ, NV Latzinik, YF Gorskaya, EA Luria, and IL Moskvina. (1999). Bone marrow stromal colony formation requires stimulation by haemopoietic cells. Bone Miner 18:199-213.
10. Monje P, MJ Marinissen, and JS Gutkind. (2003). Phosphorylation of the carboxyl-terminal transactivation domain of c-Fos by extracellular signal-regulated kinase mediates the transcriptional activation of AP-1 and cellular transformation induced by platelet-derived growth factor. Mol Cell Biol 23:7030-7043.
11. Kazlauskas A and PE di Corleto. (1986). A Comparison of platelet-derived growth factor-dependent tyrosine kinase activity in sparce and confluent fibroblasts. J Cell Physiol 126:225-236.
12. Waters CM, TD Littlewood, DC Hancock, JP Moore, and GI Evan. (1991). Related Articles, Links, c-myc protein expression in untransformed fibroblasts. Oncogene 6(5):797-805.
13. Izumi H, C Molander, LZ Penn, A Ishisaki, K Kohno, and K Funa. (2001). Mechanism for the transcriptional repression by c-Myc on PDGF beta-receptor. J Cell Sci 114: 1533-1544.
14. Harrington EA, MR Bennett, A Fanidi, and GI Evan. (1994). c-Myc induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J 13:3286-3295.
15. Okada S, T Fukuda, K Inada, and T Tokuhisa. (1999). Prolonged Expression of c-fos suppresses cell cycle entry of dormant hematopoietic stem cells. Blood 93:816-825.
16. Dang CV. (1999). c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 19:1-11.
17. Chasseing NA, YG Trejo, RH Bordenave, EO Bullorsky, NB Diaz, and LS Rumi. (1997). Bone marrow fibroblastic progenitors in patients with advanced breast cancer. Breast Cancer Res Treat 45:211-218.
18. Chasseing NA, RH Bordenave, EO Bullorsky, NB Diaz, GR Stemmelin, LS Rumi. (1997). Fibroblastic colony forming units and levels of tumor necrosis factor alpha and prostaglandin E2 in bone marrow cultures from patients with advanced lung cancer. Cancer 80:1914-1919.
19. Honegger A, EL Hofer, RI Baranao, TA Mackinlay, DA Mackinlay, EO Bullorsky, RH Bordenave and NA Chasseing. (2002). Interleukin-1 beta, transforming growth factor beta-1, prostaglandin E2 and fibronectin levels in the conditioned mediums of bone marrow fibroblast cultures from lung and breast cancer patients. Ann Hematol 81: 80-85.
20. Chasseing N, A Honegger, R Bordenave, E Hofer, C Shandley and L Rumi. (1999). "Effect of conditioned medium of bone marrow fibroblast colony forming units (CFU-F) from patients with solid tumor on the growth of normal CFU-F" (abstract). Eur J Cancer 35:383. 108.
21. Hofer E, A Honegger, E Bullorsky, J Martinez and N Chasseing. (2001). Production of stimulating and inhibiting factors of bone marrow fibroblast colonies in untreated lung and breast cancer patients (abstract) Haematol J 1:253. 74.
22. Castro-Malaspina H, RE Gay, G Resnick, N Kapoor, P Meyers, D Chiarieri, S McKenzie, HE Broxmeyer and MAS Moore. (1980). Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 56:289-301.
23. Paulsson Y, M Bywater, CH Heldin and B Westermark. (1987). Effects of epidermal growth factor and platelet-derived growth factor on c-fos and c-myc mRNA levels in normal human fibroblasts. Exp Cell Res 171:186-194.
24. Dooley DC, BK Oppenlander, P Spurgin, JH Mead, FP Novak, M Plunkett, J Beckstead and MC Heinrich. (1995). Basic fibroblasts growth factor and epidermal growth factor downmodulate the growth of hematopoietic cells in long-term stromal cultures. J Cell Physiol 165:386-397.
25. Yoon SY, A Tefferi and CY Li. (2000). Cellular distribution of platelet-derived growth factor, transforming growth factor-β, basic fibroblasts growth factor and their receptors in normal bone marrow. Acta Hematolog 104:151-157.
26. Barry FP, RE Boynton, S Haynesworth, JM Murphy and J Zaia. (1999). The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD 105). Biochem Biophys Res Commun 265:134-139.
27. Cheifetz S, T Bellon, C Cales, S Vera, C Bernabeu, J Massague and M Letarte. (1992). Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem 267:19027-19030.
28. Claassen GF and SR Hann. (2000). A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta-induced cell-cycle arrest. Proc Natl Acad Sci USA 97:9498-9503.
29. Beresford JN. (1989). Osteogenic stem cells and the stromal system of bone and marrow. Clin Orthop 240:270-280.
30. Bonyadi M, SD Waldman, D Liu, JE Aubin, MD Grynpas and WL Stanford. (2003). Mesenchymal progenitor of self-renewal deficiency leads to age-dependent osteoporosis in Sea-1/Ly-6A null mice. Proc Natl Acad Sci USA 100: 5840-5845.
31. Hofer EL, D Caramutti, V La Russa, L Feldman, RH Bordenave and NA Chasseing. (2004). Osteogenic potential of bone marrow mesenchymal cells from chemonaive advanced breast cancer patients, as prognostic factor in bone diseases. Cytotherapy, abstract 27 (in press).
32. Compston JE. (2002). Bone marrow and bone: a functional unit. J Endocrinol 173:387-394.